Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-25

Clinical Trial Update: Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial updating a regimen of paclitaxel and carboplatin or bleomycin sulfate, etoposide phosphate, and cisplatin in advanced or recurrent sex cord-stroma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin sulfate (Bleomycin sulfate)
  • CARBOPLATIN (Carboplatin)
  • CISPLATIN (cisplatin)
  • Etoposide phosphate (etoposide phosphate)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GOG Foundation | Conditions: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma | Phase 2 | Status: UNKNOWN | Results posted: 2022-01-25